Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform.
about
The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistryCurrent status and future prospects for enabling chemistry technology in the drug discovery processSeamless integration of dose-response screening and flow chemistry: efficient generation of structure-activity relationship data of β-secretase (BACE1) inhibitors.Integrated Platform for Expedited Synthesis-Purification-Testing of Small Molecule Libraries.Suzuki-Miyaura cross-coupling optimization enabled by automated feedback.Accessing new chemical entities through microfluidic systems.Microfluidics: reframing biological enquiry.Active learning for computational chemogenomics.Unlocking the potential benefits of flow chemistry in the drug-discovery process.Future De Novo Drug Design.Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug DiscoveryGeneration and Trapping of Ketenes in Flow.Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.A segmented flow platform for on-demand medicinal chemistry and compound synthesis in oscillating droplets.Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatographySynthesis, Structure and Antitumoural Activity of Triazole-Functionalised NHC-Metal Complexes
P2860
Q26783484-233DEDEE-F1F3-4427-8EDE-14DA15BF33CAQ28066266-FFD917EA-BE24-44F5-AB99-9B60CC2A5BEDQ30741444-6BBD3575-2007-4E8C-B87C-BD1B169D72A3Q36354649-1B8F0E1B-45B7-40A7-BE82-5A11C000374BQ37441389-3143BA57-5B56-4F23-A9F9-EA9322F156C0Q38209736-A71B1C03-E7C6-4504-B0FE-7B37B3B19B7BQ38571113-D238C34D-00E6-463D-977D-EEBEB02E68D0Q38750215-95C78DB7-C184-461A-AD9E-B0D163D7D7F8Q39170518-8E8CB3F3-3324-4719-B4B1-C37ACCFC9D62Q39184034-9C90C101-AC6A-40D7-9D19-6A1E435138D2Q39771545-2B6CF3D6-3DE4-457C-AC83-E548D0C8BDBAQ41841128-B98AB9C2-02E3-4B1F-82C6-B7B046CE2448Q48156075-C20A46AE-F5FD-4CA1-A88C-209F2A6A68DDQ50851040-A741A735-9515-4E2D-B773-57CAA1BEB00EQ56951623-EF213227-CCF2-49E1-BEAD-011AA6B1D4C0Q58239301-CAAE2CCB-768D-4CA2-B6C0-AEE894E61E2F
P2860
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Rapid discovery of a novel ser ...... thesis and screening platform.
@en
Rapid discovery of a novel ser ...... thesis and screening platform.
@nl
type
label
Rapid discovery of a novel ser ...... thesis and screening platform.
@en
Rapid discovery of a novel ser ...... thesis and screening platform.
@nl
prefLabel
Rapid discovery of a novel ser ...... thesis and screening platform.
@en
Rapid discovery of a novel ser ...... thesis and screening platform.
@nl
P2093
P356
P1476
Rapid discovery of a novel ser ...... nthesis and screening platform
@en
P2093
Adrian G Wright
Bimbisar Desai
Christopher N Selway
Elizabeth Farrant
Gary J Tarver
Gavin Whitlock
James Mills
Karen Dixon
Karl R Gibson
Manoj K Ramjee
P304
P356
10.1021/JM400099D
P407
P577
2013-03-25T00:00:00Z